Othmar Moser1,2,3*
Klemen Dovc4,5- 1Exercise Physiology and Metabolism, Institute of Sports Science, University of Bayreuth, Bayreuth, Germany
- 2Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
- 3Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria
- 4Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children’s Hospital, Ljubljana, Slovenia
- 5Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Editorial on the Research Topic
Daily challenges around physical exercise, nutrition and medication in type 1 diabetes
Type 1 diabetes is characterized by autoimmune destruction of insulin-secreting pancreatic β-cells leading to disturbed glucose regulation and overt hyperglycemia. Consequently, individuals with type 1 diabetes have a lifelong need for insulin replacement therapy. The primary goal in the long-term care of type 1 diabetes is to maintain glucose levels physiologically as possible, mitigating the risk of micro- and macrovascular complications, which combined represent the primary cause of morbidity and mortality in developed societies (1–4). Recent advancements in diabetes technologies have revolutionized disease management, with (semi)automated and glucose-responsive treatment modalities allowing individuals to optimize glycemia, improve quality of life, and reduce the burden of type 1 diabetes. Furthermore, there has also been reported a global increase in uptake into everyday clinical practice (5–10). Alongside insulin replacement therapy, physical activity and exercise combined with a well-balanced diet are cornerstones in the management of diabetes. In numerous studies, it was demonstrated that regular physical activity improves glycemic outcomes and the quality of life compared to a sedentary lifestyle (11–15). Physical activity, especially structured exercise, has long been proposed as a major hurdle for automatic insulin delivery systems, and studies are now looking into how these systems are performing around physical activity (16–19). Exercise duration, modality, relative and absolute intensity, and fitness capacity (among others) affect glucose homeostasis in people living with type 1 diabetes. Several strategies for insulin adjustments and additional carbohydrate consumption regarding physical activity and exercise have been suggested, and these recommendations should be individualized and tailored based on the above-mentioned factors and treatment modalities (20–25).
Due to the inhomogeneous nature of physical activity exercise, activity-related hormonal responses, and different gender and age responses to physical activity, a personalized glucose management and nutritional plan should be followed.
This Research Topic of Daily Challenges Around Physical Exercise, Nutrition and Medication in Type 1 Diabetes covers diverse topics of both pre-clinical and clinical studies, addressing relevant questions surrounding the everyday decisions that individuals with type 1 diabetes encounter to overcome dysglycemia.
McCarthy et al. in their review “The endocrine pancreas during exercise in people with and without type 1 diabetes: Beyond the beta-cell” discussed the crucial role of the endocrine pancreas, beyond its role in digestion and metabolism at rest, in regulating energy during physical exercise. In type 1 diabetes, the destruction of β-cells leads to significant disruptions in glucose control; however, the impact of type 1 diabetes on other pancreatic hormones response during exercise and how they differ from individuals without type 1 diabetes are less investigated. Understanding these responses in both individuals with and without diabetes can help to identify clinically relevant adaptations for effective management of glucose levels around exercise, thus providing optimal clinical care through educated decision making. This knowledge is particularly relevant with the advancement of automated insulin delivery and emerging algorithms that detect physical activity, as it can bridge the gap between clinical and engineering considerations for automatic insulin delivery requirements during physical activity.
Barlovic et al. evaluated in their review “Exercise and nutrition in type 1 diabetes: Insights from the FinnDiane cohort” the main findings from the Finnish Diabetic Nephropathy Study (FinnDiane), a long-term research project involving over 8,000 individuals with type 1 diabetes over a period of 25 years. The authors discuss different topics from research in this well-studied cohort, including associations between physical activity, glycemic outcomes, chronic complications, and mortality or associations between different aspects of nutrition, glycemic outcomes, and chronic complications of type 1 diabetes. Importantly, this discussion of the FinnDiane project further underpins the importance of living a physically active lifestyle with type 1 diabetes.
Fitzpatrick et al. described in their paper “Exercise, type 1 diabetes mellitus and blood glucose: The implications of exercise timing” that the timing of exercise may play a crucial role in preventing glucose imbalances such as post-exercise hypo- or hyperglycemia. There is limited evidence summarizing the impact of exercise timing on glucose metabolism in type 1 diabetes; in this report, the authors suggest that resistance training or high-intensity interval training (HIIT) should be performed in the afternoon/evening when individuals are more likely to experience hypoglycemia since these types of exercise provide more glucose stability or even an increase in glucose levels. However, continuous aerobic exercise is recommended in the morning due to natural circadian elevations in blood glucose, providing additional protection against exercise-induced hypoglycemia. However, more well-designed studies are needed to further investigate the relationship between exercise timing and glycemic control, ultimately determining the most effective and safe exercise timing for individuals with type 1 diabetes.
Rilstone et al. provided in their study “Nutritional support for a person with type 1 diabetes undertaking endurance swimming” information about nutritional considerations for people with type 1 diabetes participating in long-distance open-water events, including personal testimony from a marathon swimmer with type 1 diabetes. Individuals with type 1 diabetes face additional complexities related to insulin management and manage it through high carbohydrate intake. This paper aims to provide insights and recommendations for individuals with type 1 diabetes engaging in long-distance swimming activities, highlighting the main considerations and suggestions for insulin management strategies.
Valder and Brinkmann in their opinion article “Is intake of fruit juice useful in exercise-induced hypoglycemia prevention in individuals with type 1 diabetes mellitus?” discussed the role of fruit juice in preventing exercise-induced hypoglycemia in individuals with type 1 diabetes and addressed associated health concerns. The authors provided some practical recommendations regarding nutrition, carbohydrate intake amount, and glucose monitoring before, during, and after physical activity. Very clinically relevant to note for people with type 1 diabetes, when fructose is consumed during exercise, this might further increase systemic lactate concentration, and the extent of blood glucose increase might be lower when compared to glucose consumption.
Vlcek et al. reported in their patient-led qualitative study “How we do it: A qualitative study of strategies for adopting an exercise routine while living with type 1 diabetes” the experiences of individuals living with type 1 diabetes on how they adopt and maintain an active lifestyle while managing the risks of hypoglycemia and glucose fluctuations. Semi-structured interviews and focus groups were conducted, and interpretive description analysis was used to identify themes and strategies associated with staying physically active with type 1 diabetes. In their study, the authors found that structure and organization, trial and error learning, psychosocial aspects, diabetes technology, education, and peer support were key facilitators of regular physical activity. Strategies to overcome barriers included utilizing technology, integrating psychosocial support, adjusting insulin and carbohydrate intake, and planning when and how to perform exercise. Their findings emphasize the importance of personalized approaches, understanding individual glycemic responses, and incorporating supportive tools and resources for individuals with type 1 diabetes to maintain an active lifestyle.
Gianini et al. demonstrated in their article “Patient reported outcome measures in children and adolescents with type 1 diabetes using advanced hybrid closed loop insulin delivery” that the use of advanced automatic insulin delivery systems resulted in decreased fear of hypoglycemia, less emotional distress, increased quality of life, and reduced burden of type 1 diabetes management together with improved metrics of glycemia. This was investigated by utilizing mixed methods research design using both quantitative and qualitative approaches.
Within the last article in our Research Topic, Zaharieva et al. in “Adding glycemic and physical activity metrics to a multimodal algorithm-enabled decision-support tool for type 1 diabetes care: Keys to implementation and opportunities” presented an overview of the essential steps of integrating exercise data into an algorithm-enabled patient prioritization and remote patient monitoring program. This care model integrates continuous glucose monitoring data to prioritize patients for weekly reviews by clinical diabetes, has improved clinical workflows, and has been associated with improved glucose outcomes in newly diagnosed young people with type 1 diabetes. Incorporating exercise data (such as step count or heart rate) into the current continuous glucose monitoring (CGM)-based care model could produce additionally clinically relevant information such as identifying whether individuals are meeting physical activity recommendations and would allow for personalized care and better-informed decisions around individual needs, insulin-dosing decisions, and overall diabetes management.
Author contributions
OM: Writing – original draft, Writing – review & editing. KD: Writing – original draft, Writing – review & editing.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. The DCCT Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr (1994) 125(2):177–88.
2. Lind M, Svensson A-M, Kosiborod M, Gudbjörnsdottir S, Pivodic A, Wedel H, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med [Internet] (2014) 371(21):1972–82. doi: 10.1056/NEJMoa1408214
3. Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections the gold randomized clinical trial. JAMA - J Am Med Assoc (2017) 317(4):379–87. doi: 10.1001/jama.2016.19976
4. Rawshani A, Sattar N, Franzén S, Rawshani A, Hattersley AT, Svensson AM, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet (2018) 392(10146):477–86. doi: 10.1016/S0140-6736(18)31506-X
5. Van Den Boom L, Karges B, Auzanneau M, Rami-Merhar B, Lilienthal E, Von Sengbusch S, et al. Temporal trends and contemporary use of insulin pump therapy and glucose monitoring among children, adolescents, and adults with type 1 diabetes between 1995 and 2017. Diabetes Care (2019) 42(11):2050–6. doi: 10.2337/dc19-0345
6. Addala A, Auzanneau M, Miller K, Maier W, Foster N, Kapellen T, et al. A decade of disparities in diabetes technology use and HBA1c in pediatric type 1 diabetes: A transatlantic comparison. Diabetes Care (2021) 44(1):133–40. doi: 10.2337/dc20-0257
7. Deshmukh H, Wilmot EG, Gregory R, Barnes D, Narendran P, Saunders S, et al. Effect of flash glucose monitoring on glycemic control, hypoglycemia, diabetes-related distress, and resource utilization in the association of british clinical diabetologists (Abcd) nationwide audit. Diabetes Care (2020) 43(9):2153–60. doi: 10.2337/dc20-0738
8. Charleer S, Mathieu C, Nobels F, De Block C, Radermecker RP, Hermans MP, et al. Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: A real-world study. J Clin Endocrinol Metab (2018) 103(3):1224–32. doi: 10.1210/jc.2017-02498
9. Dovc K, Lanzinger S, Cardona-Hernandez R, Tauschmann M, Marigliano M, Cherubini V, et al. Association of achieving time in range clinical targets with treatment modality among youths with type 1 diabetes. JAMA Netw Open (2023) 6(2):e230077. doi: 10.1001/jamanetworkopen.2023.0077
10. Leelarathna L, Evans ML, Neupane S, Rayman G, Lumley S, Cranston I, et al. Intermittently scanned continuous glucose monitoring for type 1 diabetes. N Engl J Med (2022) 387(16):1477–87. doi: 10.1056/NEJMoa2205650
11. Beraki Å, Magnuson A, Särnblad S, Åman J, Samuelsson U. Increase in physical activity is associated with lower HbA1c levels in children and adolescents with type 1 diabetes: Results from a cross-sectional study based on the Swedish pediatric diabetes quality registry (SWEDIABKIDS). Diabetes Res Clin Pract (2014) 105(1):119–25. doi: 10.1016/j.diabres.2014.01.029
12. Anderson BJ, Laffel LM, Domenger C, Danne T, Phillip M, Mazza C, et al. Factors associated with diabetes-specific health-related quality of life in youth with type 1 diabetes: The global teens study. Diabetes Care (2017) 40(8):1002–9. doi: 10.2337/dc16-1990
13. Riddell MC, Li Z, Gal RL, Calhoun P, Jacobs PG, Clements MA, et al. Examining the acute glycemic effects of different types of structured exercise sessions in type 1 diabetes in a real-world setting: the type 1 diabetes and exercise initiative (T1DEXI). Diabetes Care (2023) 46(April):704–13. doi: 10.2337/dc22-1721
14. Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, et al. Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol (2017) 5(5):377–90. doi: 10.1016/S2213-8587(17)30014-1
15. Macmillan F, Kirk A, Mutrie N, Matthews L, Robertson K, Saunders DH. A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: Study characteristics, intervention design, and efficacy. Pediatr Diabetes (2014) 15(3):175–89. doi: 10.1111/pedi.12060
16. Zaharieva DP, Messer LH, Paldus B, O’Neal DN, Maahs DM, Riddell MC. Glucose control during physical activity and exercise using closed loop technology in type 1 diabetes. Can J Diabetes (2020). doi: 10.1016/j.jcjd.2020.06.003
17. Paldus B, Morrison D, Zaharieva DP, Lee MH, Jones H, Obeyesekere V, et al. A randomized crossover trial comparing glucose control during moderate-intensity, high-intensity, and resistance exercise with hybrid closed-loop insulin delivery while profiling potential additional signals in adults with type 1 diabetes. Diabetes Care (2021), dc211593.
18. Dovc K, Bergford S, Fröhlich-Reiterer E, Zaharieva DP, Potocnik N, Müller A, et al. A comparison of faster insulin aspart to standard insulin aspart using hybrid automated insulin delivery system in active children and adolescents with type 1 diabetes: A randomized, double-blind crossover trial. Diabetes Technol Ther (2023), 1–25. doi: 10.1089/dia.2023.0178
19. Eckstein ML, Weilguni B, Tauschmann M, Zimmer RT, Aziz F, Sourij H, et al. Time in Range for Closed-Loop Systems versus Standard of Care during Physical Exercise in People with Type 1 Diabetes : A Systematic Review and Meta-Analysis. (2021), 1–12.
20. Thabit H, Leelarathna L. Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot. Diabetologia (2016) 59(8):1628–31. doi: 10.1007/s00125-016-4010-8
21. McAuley SA, Horsburgh JC, Ward GM, La Gerche A, Gooley JL, Jenkins AJ, et al. Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study. Diabetologia (2016) 59(8):1636–44. doi: 10.1007/s00125-016-3981-9
22. Diabetes Research in Children Network (DirecNet) Study Group, Tsalikian E, Kollman C, Tamborlane WB, Beck RW, Fiallo-Scharer R, et al. Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care (2006) 29(10):2200–4. doi: 10.2337/dc06-0495
23. Pivovarov JA, Taplin CE, Riddell MC. Current perspectives on physical activity and exercise for youth with diabetes. Pediatr Diabetes [Internet] (2015) 16(4):242–55. doi: 10.1111/pedi.12272
24. Zaharieva D, Yavelberg L, Jamnik V, Cinar A, Turksoy K, Riddell MC. The effects of basal insulin suspension at the start of exercise on blood glucose levels during continuous versus circuit-based exercise in individuals with type 1 diabetes on continuous subcutaneous insulin infusion. Diabetes Technol Ther (2017) 19(6):370–8. doi: 10.1089/dia.2017.0010
Keywords: exercise, type 1 diabetes, insulin, automatic insulin delivery, continuous glucose monitoring
Citation: Moser O and Dovc K (2023) Editorial: Daily challenges around physical exercise, nutrition and medication in type 1 diabetes. Front. Endocrinol. 14:1259535. doi: 10.3389/fendo.2023.1259535
Received: 16 July 2023; Accepted: 18 July 2023;
Published: 31 July 2023.
Edited and Reviewed by:
Åke Sjöholm, Gävle Hospital, SwedenCopyright © 2023 Moser and Dovc. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Othmar Moser, b3RobWFyLm1vc2VyQHVuaS1iYXlyZXV0aC5kZQ==